Ecolab Inc (NYSE:ECL) shares are trading higher after the company reported better-than-expected fourth-quarter FY23 results and issued first-quarter FY24 adjusted EPS guidance above estimates.
Sales grew 7% Y/Y to $3.938 billion, marginally beating the analyst consensus estimate of $3.933 billion.
Sales from Global Industrial rose 3%, Global Institutional & Specialty climbed 13%, and Global Healthcare & Life Sciences fell 1% Y/Y in fixed currency.
Selling, general and administrative expenses rose 12% Y/Y. Adjusted operating income increased 24% Y/Y to $624.5 million, and the operating margin expanded ...